MMP3 rs1052536: Tendon Health and Soft Tissue Genetics
The rs1052536 variant is a common single-nucleotide polymorphism located in the MMP3 gene, which encodes stromelysin-1, an enzyme critical for remodeling extracellular connective tissues. Small candidate-gene studies have investigated rs1052536 for potential links to soft tissue injury risks, such as Achilles tendinopathy and ligament tears, particularly in athletic populations. However, broad scientific evidence remains limited, and larger population-scale genome-wide association studies have not conclusively confirmed these candidate-gene findings.
What each genotype means
Typical soft tissue injury risk
You carry two copies of the A allele for the MMP3 rs1052536 variant. In sports genomics studies, this genotype has generally been correlated with standard baseline rates of Achilles tendinopathy and soft tissue strain compared to G allele carriers. However, evidence remains limited and overall injury risk is heavily influenced by training volume, biomechanics, and recovery protocols.
Found in approximately 27% of individuals of European ancestry and roughly 25% to 35% across many global populations.
Slightly increased soft tissue vulnerability
You carry one copy of the A allele and one copy of the G allele for the MMP3 rs1052536 marker. Some athletic cohort studies suggest that carrying the G allele may modestly influence matrix metalloproteinase-3 activity and tendon remodeling during repetitive mechanical load. Because research findings are mixed and limited in sample size, this genetic factor alone does not predict tendon injury.
Present in about 50% of people of European ancestry, representing the most common genotype in many studied cohorts.
Elevated Achilles tendinopathy risk
You carry two copies of the G allele for the MMP3 rs1052536 polymorphism. Published case-control studies have noted an overrepresentation of the GG genotype among athletes presenting with Achilles tendinopathy or tendon pathology, possibly reflecting altered collagen matrix turnover. Nonetheless, the overall scientific evidence is preliminary and limited, meaning proper load management and conditioning remain the primary determinants of tendon health.
Observed in roughly 23% of individuals of European ancestry, with similar prevalence in several other continental groups.
Genomic Location and Variant Characteristics
The single-nucleotide polymorphism rs1052536 is situated on human chromosome 11 within the MMP3 (matrix metallopeptidase 3) gene. In standard genomic reference databases such as dbSNP, the variation is defined by an exchange between the nucleobases cytosine (C) and thymine (T). The MMP3 locus is part of a broader cluster of matrix metalloproteinase genes that regulate the degradation and maintenance of structural components across human connective tissues. While candidate-gene research often evaluates single polymorphisms like rs1052536 individually or in haplotype blocks alongside promoter variants, modern functional databases classify rs1052536 primarily as a non-coding or synonymous marker. As a common genomic variant, it co-segregates widely across diverse populations and acts as a marker within European and non-European genetic backgrounds.
Biological Role of the MMP3 Gene
The MMP3 gene encodes matrix metalloproteinase-3, also historically referred to as stromelysin-1. This secreted zinc-dependent endopeptidase plays an essential physiological role in extracellular matrix turnover, wound healing, and tissue remodeling. MMP-3 has broad substrate specificity, meaning it actively cleaves many connective proteins including proteoglycans, fibronectin, laminin, and several types of non-fibrillar collagens. Furthermore, MMP-3 can biochemically activate other inactive pro-collagenases, amplifying cellular matrix degradation during tissue stress or repair cascades. In healthy tendons and ligaments, a continuous balance between collagen breakdown by metalloproteinases and new matrix deposition is necessary to maintain tensile strength. Perturbations in baseline MMP-3 enzymatic activity or expression levels can therefore theoretically influence how tendons adapt to mechanical loading and recover from repetitive mechanical stress.
Evaluating the Evidence on Soft Tissue Injuries
Sports genomics literature has frequently evaluated MMP3 variants in relation to musculoskeletal soft tissue conditions, specifically Achilles tendinopathy, chronic tendon pathology, and anterior cruciate ligament (ACL) injuries. Early candidate-gene case-control cohorts reported statistical associations between specific alleles of MMP3 and altered odds of developing Achilles tendon injuries among athletic cohorts. However, the scientific strength of this evidence is classified as limited. A recurring limitation in sports genetic research is small sample size, which increases the likelihood of false-positive associations. Notably, large genome-wide association studies (GWAS), such as high-powered analyses conducted using biobank cohorts, have failed to replicate the reported candidate-gene associations between MMP3 variants and Achilles tendon pathology. Consequently, genetics experts urge caution, recognizing that while biological plausibility exists, statistical causality remains unproven.
Clinical Utility and Lifestyle Considerations
Learning your rs1052536 genotype cannot diagnose any medical condition, nor can it predict with certainty whether an individual will sustain a tendon injury. Musculoskeletal health is complex and multifactorial, heavily dictated by training volume, biomechanics, previous injury history, recovery periods, and footwear rather than any single DNA marker. Genetic testing results for rs1052536 should not be used to justify extreme changes in physical training programs or to dictate orthopedic treatments. Athletes and active individuals concerned about soft tissue vulnerability should focus on validated, evidence-based practices: managing training load progressively, incorporating eccentric strengthening exercises, allowing adequate recovery between strenuous sessions, and seeking guidance from physical therapists or sports medicine clinicians when persistent pain arises.
How common is this variant?
The rs1052536 variant is common worldwide, with the minor allele frequency estimated at approximately 0.48 in individuals of European ancestry according to broad population reference data.
Frequently asked questions
Can testing rs1052536 tell me if my Achilles tendon will tear?
No. Carrying a particular genotype at rs1052536 does not mean you will rupture or injure a tendon. Tendon injuries are multifactorial conditions largely driven by physical training loads, biomechanics, age, and recovery, with single genetic variants playing only minor, unconfirmed roles.
Should I modify my workout routine based on my MMP3 genotype?
Genomic experts do not recommend changing physical exercise programs solely based on MMP3 variants like rs1052536. Instead, follow standard athletic conditioning principles such as progressive overload, adequate rest, and proper form to maintain tendon resilience.
Why do candidate gene studies and GWAS studies show different results for MMP3?
Early candidate gene studies often tested modest sample sizes, which can lead to statistical noise and false-positive findings. In contrast, modern genome-wide association studies analyze hundreds of thousands of individuals and have not confirmed a strong, reproducible link between MMP3 and tendon injuries.
Is MMP3 rs1052536 considered a medical diagnostic marker?
No, rs1052536 is not recognized as a diagnostic or clinical marker by standard medical genetics authorities. It is explored primarily within academic research settings focused on musculoskeletal connective tissue biology.
Sources & further reading
Educational information only, last refreshed 9/14/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1052536?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in MMP3
The 5A/6A promoter polymorphism modulates MMP3 expression; the 5A allele has been investigated for associations with tendon pathology, though results across different athletic populations are inconsistent.
A missense variant (p.Glu45Lys) in stromelysin-1 (MMP3) that alters stromal extracellular matrix turnover and has been associated with pronounced facial elastosis and solar wrinkling.